Pozen Announces Strategic Acquisition of Tribute
Troutman Sanders was mentioned in numerous publications – BioCentury, Digital Journal, ClinicaSpace, Pharmacy Choice, Smart Grid, Stockwatch, TD Waterhouse and others-about North Carolina-based pharmaceutical company Pozen Inc. acquiring Tribute Pharmaceuticals Canada, Inc. in a deal valued at approximately U.S. $146 million (combined market cap of approximately U.S.$400 million) in a U.S. tax inversion transaction. Once the transaction is completed in the fourth quarter of 2015 – which will be accompanied by an infusion of U.S. $350 million of new capital in the form of equity, debt and a credit line – the combined company will be a new Irish company, Aralez Pharmaceuticals plc.
Troutman Sanders corporate lawyers Tom Rose, David Ghegan, Neil Kinnebrew and Kristen O’Connor; tax lawyer Mark Goldsmith; IP lawyer Heather Ettinger and team; benefits and employment lawyer Jeff Banish and team; lending lawyer Mike Karpen; HSR lawyer Mitch Portnoy; and CFIUS lawyer Megan Rahman served as U.S. legal counsel for Tribute in the deal.